In this tumor board, the participants will hear a case-based discussion that will include: 

• Surgical and systemic treatment options for oligometastatic disease and factors that influence decision making towards a systemic therapy or surgical option.
• Options for patients who present with regional recurrences despite adjuvant systemic therapy.
• Treatment of in-transit melanoma including intralesional therapies, regional therapies and systemic options.